Al-Ola Abdallah and Daniel Carrizosa
Aug 5, 2025, 16:13
Al-Ola Abdallah: Daniel Carrizosa Discussed Bispecific T-cell Engagers in SCLC at National ICE-T Conference
Al-Ola Abdallah, Associate Professor of Medicine at the University of Kansas Medical Center, shared on X:
“At the National ICE T conference, Dr. Daniel Carrizosa discussed bispecific T-cell engagers (BiTEs) in small cell lung cancer, spotlighting tarlatamab-dlle (Imdelltra) – approved in May 2024 for ES-SCLC.
A promising new frontier in immunotherapy.”
More posts featuring Al-Ola Abdallah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 5, 2025, 16:07
Aug 5, 2025, 16:04
Aug 5, 2025, 14:16
Aug 5, 2025, 13:23
Aug 5, 2025, 12:52
Aug 5, 2025, 12:39